Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Actoverco
Tehran, Tehran, Iran
- Ownership
- Private
- Employees
- ~4500
- Development stage
- Other
01
Overview
Actoverco is a leading pharmaceutical and biotechnology group in the Middle East, primarily focused on the Iranian market. It specializes in the production of high-tech biosimilars, oncology treatments, and vaccines, including the local production of international brands under license. The company has a significant portfolio of over 250 products and maintains strategic partnerships with several multinational pharmaceutical companies.
- Therapeutic areas
- ImmunologyEndocrinologyCardiovascularNeurologyInfectious DiseasesOncology
- Modalities
- Small moleculeMonoclonal antibodyVaccineBiologicPeptidesRecombinant protein
- Industry
- Biotech
02
Partnerships
Beyond the preview
Go deeper on Actoverco.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Actoverco.